Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

[The efficacy of the fixed drug combination dorzolamide 2%/timolol 0.5% in patients with primary open angle glaucoma].

Kovaić Z, Stanić R, Bojić L, Rogosić V, Ivanisević M, Jurasin KS, Capkun V.

Lijec Vjesn. 2012 May-Jun;134(5-6):155-8. Croatian.

PMID:
22930933
2.

Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.

Ormrod D, McClellan K.

Drugs Aging. 2000 Dec;17(6):477-96. Review.

PMID:
11200308
3.

Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.

Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA; COSOPT versus XALATAN Study Groups.

Acta Ophthalmol Scand. 2004 Feb;82(1):42-8.

7.

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.

Boyle JE, Ghosh K, Gieser DK, Adamsons IA.

Ophthalmology. 1999 Dec;106(12 Suppl):10-6.

PMID:
10598692
8.

[Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].

Kałuzny JJ, Szaflik J, Czechowicz-Janicka K, Kałuzny J, Orzałkiewicz A, Zaleska-Zmijewska A, Krajewska M, Stewart JA, Leech JN, Stewart WC.

Klin Oczna. 2004;106(1-2 Suppl):241-2. Polish.

PMID:
15510513
9.
10.

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.

Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.

Ophthalmology. 2003 Mar;110(3):615-24.

PMID:
12623832
12.
14.

The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.

Strohmaier K, Snyder E, DuBiner H, Adamsons I.

Ophthalmology. 1999 Dec;106(12 Suppl):1-9.

PMID:
10598691
15.
16.

Three-month evaluation of dorzolamide hydrochloride/timolol maleate fixed-combination eye drops versus the separate use of both drugs.

Inoue K, Shiokawa M, Sugahara M, Wakakura M, Soeda S, Tomita G.

Jpn J Ophthalmol. 2012 Nov;56(6):559-63. doi: 10.1007/s10384-012-0186-8. Epub 2012 Sep 22.

PMID:
23001284
17.

Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.

Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.

Ann Pharmacother. 2008 Apr;42(4):498-504. doi: 10.1345/aph.1K565. Epub 2008 Mar 25.

PMID:
18364402
18.

Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.

Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.

Curr Med Res Opin. 2009 Jul;25(7):1645-53. doi: 10.1185/03007990902994041.

PMID:
19476406
19.

Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma.

Konstas AG, Maltezos A, Bufidis T, Hudgins AG, Stewart WC.

Eye (Lond). 2000 Feb;14 ( Pt 1):73-7.

PMID:
10755105
20.

Supplemental Content

Support Center